RESULTS	222 deaths occurred in the exemestane group compared with 261 deaths in the tamoxifen group ; unadjusted hazard ratio 0.85 ( 95 % CI 0.71-1 .02 , p = 0.08 ) , 0.83 ( 0.69-1 .00 , p = 0.05 ) when 122 patients with oestrogen-receptor-negative disease were excluded .\